PHARMAKOKINETIC

Clinical trials for PHARMAKOKINETIC explained in plain language.

Never miss a new study

Get alerted when new PHARMAKOKINETIC trials appear

Sign up with your email to follow new studies for PHARMAKOKINETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Fibromyalgia drug tested in elderly: how does age affect the medicine?

Knowledge-focused Ongoing

This study looks at how the body processes TNX-102 SL (a drug for fibromyalgia) in two age groups: non-elderly (18-45 years) and elderly (65 years and older). About 50 healthy or stable participants will receive a single dose. The goal is to see if age changes drug levels and saf…

Matched conditions: PHARMAKOKINETIC

Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused

Last updated May 17, 2026 10:11 UTC

PHARMAKOKINETIC

Get alerted when new PHARMAKOKINETIC trials appear

Fibromyalgia drug tested in elderly: how does age affect the medicine?